Overview Welcome to Dechra's 2020 Annual Report Chairman's View Dechra's Strengths Highlights Our Purpose and Strategy Our Geographical Footprint Strategic Report Delivering Our Purpose Our Marketplace Global Market Dynamics Product Market Dynamics Our Business Model Creating Value For Our Stakeholders Delivering Our Strategy Overview Our Achievements and Progress Chief Executive Officer's Statement Financial Review Key Performance Indicators Strategy in Action People Technology Manufacturing and Supply Chain Product Development Product Development Process Product Development Pipeline International Product Offering Section 172 Statement Corporate Social Responsibility Overview Our People Our Environment Our Business Our Community Non-Financial Information Statement How the Business Manages Risk Overview Understanding Our Key Risks Viability Statement Governance Delivering Our Purpose Letter from the Chairman on Governance Corporate Governance Board of Directors Senior Executive Team Non-Executive Directors Board Leadership and Company Purpose Division of Responsibilities Composition, Succession and Evaluation Audit, Risk and Internal Control Directors' Remuneration Report Letter from the Remuneration Committee Chairman Directors' Remuneration Policy 2020 Annual Report on Remuneration Directors' Report Other Disclosures Statement of Directors' Responsibilities Financial Statements Independent Auditors' Report to the Members of Dechra Pharmaceuticals PLC Consolidated Income Statement Consolidated Statement of Comprehensive Income Consolidated Statement of Financial Position Consolidated Statement of Changes in Shareholders' Equity Consolidated Statement of Cash Flows Notes to the Consolidated Financial Statements Company Statement of Financial Position Company Statement of Changes in Shareholders' Equity Notes to the Company Financial Statements Financial History Company Information Delivering Our Purpose Glossary Shareholder Information Advisers